Decheng Capital

In The News

December 17, 2019	KeChow Completes $45 Million Round for Novel Cancer Drug Development
December 17, 2019	SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
December 4, 2019	Hummingbird Bioscience Raises US$19 Million in Series B Financing
November 4, 2019	SinoMed, a Medical Device Company, Stages $50 Million IPO on the Shanghai STAR Exchange
October 25, 2019	BeyondSpring Announces Pricing of Ordinary Shares
August 29, 2019	Sema4 Lands New Investors, Continues to Expand
August 12, 2019	AtriCure offers $300m for SentreHeart
July 17, 2019	BeyondSpring Announces Pricing of Public Offering of Ordinary Shares
July 17, 2019	Adaptive Biotechnologies Announces Pricing of Initial Public Offering
July 17, 2019	EpimAb Biotherapeutics Raises $74M in Series B Financing
May 17, 2019	Hangzhou's AnHeart Completes $14.6 Million A Funding from Decheng
February 14, 2019	Bioheng Closes $15 Million Funding from Decheng Capital for CAR-T Products
January 16, 2019	Alpine Immune Sciences Announces $25 Million Private Placement
January 3, 2019	Mindstrong Health Expands Series B Financing with $31M Investment led by General Catalyst